The vascular boot market is estimated to secure a valuation of US$ 1.1 billion in 2023 and is estimated to rise to US$ 1.5 billion by 2033. The market is anticipated at a CAGR of 3.2% during the forecast period. The factors accelerating the demand for vascular boots are as follows-
Growing advances in healthcare and increased R&D activities
Increased healthcare spending and increased healthcare expenditure
Increased pressure-related injuries
Increased prevalence of diabetes globally
Increased government initiatives and increased number of vascular disorder
Increased availability of point-of-care medical devices
North America dominates the vascular boot market during the forecast period
Data Points
Key Statistics
Expected Market Value in 2023
US$ 1.1 billion
Projected Market Value in 2033
US$ 1.5 billion
Growth Rate (2023 to 2033)
CAGR of 3.2%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is driving demand for Vascular Boots?
The increasing prevalence of various leg ulcers and increased accident rate of injuries driving the global market for a vascular boot during the forecast period. With the increasing aging population and increased prevalence of lymphedema and increased awareness among the population, the demand for vascular boots is likely to increase.
The increasing healthcare infrastructure and increased demand for different medical devices are expected to drive the growth of the vascular boot market during the forecast period. Also, the growing focus on R&D activities and advancement in vascular boot treatment
The increased number of spinal cord surgeries performed due to the increased rate of spinal cord injuries supplements the market growth.
Regional Analysis of Vascular Boots Sales
North America dominates the vascular boots market during the forecast period owing to the increased R&D activities and increased healthcare spending. Also, the increased awareness about the different injuries in the region is likely to drive market growth in North America.
Europe accounts for the second highest share of the vascular foot market owing to the increased prevalence of vascular-related injuries in the region. Also, the increased number of adults suffering from heels related issue drive the market growth in the region.
Asia Pacific’s vascular boot market is projected to grow in the coming years with rapidly expanding healthcare facilities and a surging aging population. Also the increased healthcare spending and awareness about diabetes and its impact on foot likely to drive market growth in the region.
Find your sweet spots for generating winning opportunities in this market.
Vascular Boots Market- Market Competitiveness
The leading players operating in the vascular boot market are Medtronic, Becton, Boston scientific corporation, Biosensor International Group, Abbott, iVascular, Cardinal Health, Dickinson & Company, B. Braun Melsungen, Terumo Corporation, BIOTRONIC SE & Co.KG among others.
The vascular boot market is highly fragmented with the presence of many large and small-scale players. The major players in the vascular boot market are focusing on strategies like mergers, partnerships acquisitions, and increasing their brand presence. Also, the leading players are focusing on innovation to develop innovative products. Following are some of the developments in the market.
The vascular boot market is expected to grow in the coming years. The increasing demand for vascular boots for patients with arterial thrombolytics is expected to drive market growth during the forecast period. Also, the availability of vascular boots in hospital pharmacies, retail pharmacies, and online stores increases the sales of the market. Several start-ups have entered the vascular boot market with innovative products and technology.
In January 2023- Cardinal Health announced that it has entered into a strategic collaboration with Palantir Technologies Inc., to design a solution that will help health systems and hospitals dynamic purchase decision insight in order to improve the bottom line.
Founded in 2010- VascuActive is developing innovative medical devices for the treatment of diabetic peripheral neuropathy involving diabetic foot, ulcer, and venous insufficiency peripheral arterial disease.
Vascular Boot Market Forecast and CAGR
According to the latest research by Fact.MR, Vascular boot market is set to witness a 5.5% growth during the year 2023 to 2033. The market is expected to witness growth owing to an increase in demand for vascular boots which offer complete and accurate offloading of the heels along with it naturally warms up the limb. Vascular boots are used by various interventionalists and surgeons.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What is Driving Demand for Vascular Boot Market?
Primary factor driving the growth of the vascular boot market is its various benefits which provide quick and easy support to the users. Total offloading is offered along with complete floating of the heel and layers. No pressure points are present in the vascular boots. Furthermore, it is properly insulated to improve the warmth level of the limb. Vascular boot devices consist of foot drop prevention wings which are removable in nature.
Moreover, vascular boot devices do not consist of natural rubber latex due to which it provides enhanced comfort level to the patients.
Vascular Boot Prevents Heels Ulcer due to this Advantageous Benefit; Vascular Boot Device Market is likely to Augment over the Forecast Period
Vascular boot is basically used on patients on arterial thrombolytics, undergoing intra-aortic pump procedures (IABP) along with post -BKA contralateral foot. Vascular boot is majorly used to prevent heel ulcers also foot drop.
Furthermore, it is also used for patients suffering from cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more. Therefore, such advantageous benefit provided by vascular boot devices augment the market growth over the forecast period.
The USA and Canada Vascular Boot Market Outlook
Rising prevalence and awareness about various injuries such as cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more, together with increasing healthcare expenditure is boosting the market growth.
Moreover, extensive R&D activities and effort by key players to develop cost-effective and advanced vascular boots are acting as major growth drivers in the USA market. Similarly, manufacturers are coming up with point-of-care devices due to a shifting trend towards patient-self-testing, which is further expected to supplement the growth of the market during the forecast period.
Moreover, technological advancements in case of vascular boot devices are likely to augment the market growth.
Europe Demand Outlook for Vascular Boot Market
Europe would witness the highest growth after North America due to the rising prevalence of the vascular related injuries in the region. According to the World Health Organization, in the European region, numerous types of heels related issues affect more than 50 million children and adults.
Cold molted feet is one of the most commonly reported diseases which is mainly affecting young people, contribute strongly to vascular injuries and lost productivity in Europe and result into increased the healthcare burden in Europe. Thus the government is taking the initiative to create awareness among the people to use vascular devices to reduce the healthcare burden.
Increasing government initiative and increasing incidences of vascular related issues in the region is expected to drive Vascular boot market in Europe.
Who are the Key Manufacturers and Suppliers of Vascular Boot Market?
Some of the leading manufacturers and suppliers of Vascular boot market Testing include Medtronic (Ireland), Becton, Boston Scientific Corporation (US), Biosensors International Group (Singapore), Abbott (US), iVascular (Spain), Cardinal Health (US), Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), and BIOTRONIK SE & Co. KG (Germany)
The Vascular boot market is fragmented with the availability of different global and regional manufacturers. Increasing focus on research and development to launch safe and effective vascular boot treatment owing to the growing need for treatment of heel related issues would explore opportunities for the manufacturers in the vascular devices market. Acquisitions and mergers and expansion of product portfolios are the strategies adopted by these companies to increase market share.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
